ADVERTISEMENT
News
Class I Recall Issued for Intravenous Antibiotic
05/08/2020
The recall affects 50-mL containers of ceftazidime and dextrose, 2 g (NDC 0264-3145-11), from lot H8J812 (Exp. 7/31/20). The product was distributed throughout the United States.
B. Braun Medical initiated the recall April 18, 2020. On April 28, 2020, the FDA issued the Class I designation.
Ceftazidime is a prescription cephalosporin antibiotic used to treat a wide variety of bacterial infections.
—Jolynn Tumolo